| Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up … HW Lo, SC Hsu, W Xia, X Cao, JY Shih, Y Wei, JL Abbruzzese, ... Cancer research 67 (19), 9066-9076, 2007 | 811 | 2007 |
| Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway HW Lo, SC Hsu, M Ali-Seyed, M Gunduz, W Xia, Y Wei, G Bartholomeusz, ... Cancer cell 7 (6), 575-589, 2005 | 652 | 2005 |
| Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors TK Rimkus, RL Carpenter, S Qasem, M Chan, HW Lo Cancers 8 (2), 22, 2016 | 644 | 2016 |
| STAT3 target genes relevant to human cancers RL Carpenter, HW Lo Cancers 6 (2), 897-925, 2014 | 547 | 2014 |
| Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2 SC Wang, HC Lien, W Xia, IF Chen, HW Lo, Z Wang, M Ali-Seyed, DF Lee, ... Cancer cell 6 (3), 251-261, 2004 | 376 | 2004 |
| Mechanisms regulating glioma invasion I Paw, RC Carpenter, K Watabe, W Debinski, HW Lo Cancer letters 362 (1), 1-7, 2015 | 366 | 2015 |
| Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival HW Lo, MC Hung British journal of cancer 94 (2), 184-188, 2006 | 363 | 2006 |
| Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer HW Lo, W Xia, Y Wei, M Ali-Seyed, SF Huang, MC Hung Cancer research 65 (1), 338-348, 2005 | 351 | 2005 |
| EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization HW Lo, SC Hsu, MC Hung Breast cancer research and treatment 95, 211-218, 2006 | 301 | 2006 |
| Nuclear‐cytoplasmic transport of EGFR involves receptor endocytosis, importin β1 and CRM1 HW Lo, M Ali‐Seyed, Y Wu, G Bartholomeusz, SC Hsu, MC Hung Journal of cellular biochemistry 98 (6), 1570-1583, 2006 | 297 | 2006 |
| Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations W Han, HW Lo Cancer letters 318 (2), 124-134, 2012 | 295 | 2012 |
| Loss of XIST in breast cancer activates MSN-c-Met and reprograms microglia via exosomal miRNA to promote brain metastasis F Xing, Y Liu, SY Wu, K Wu, S Sharma, YY Mo, J Feng, S Sanders, G Jin, ... Cancer research 78 (15), 4316-4330, 2018 | 291 | 2018 |
| Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators HW Lo, X Cao, H Zhu, F Ali-Osman Clinical cancer research 14 (19), 6042-6054, 2008 | 289 | 2008 |
| Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance HW Lo, F Ali-Osman Current opinion in pharmacology 7 (4), 367-374, 2007 | 286 | 2007 |
| Co‐regulation of B‐Myb expression by E2F1 and EGF receptor N Hanada, HW Lo, CP Day, Y Pan, Y Nakajima, MC Hung Molecular Carcinogenesis: Published in cooperation with the University of …, 2006 | 246 | 2006 |
| Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes HW Lo, X Cao, H Zhu, F Ali-Osman Molecular Cancer Research 8 (2), 232-245, 2010 | 234 | 2010 |
| A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasion HW Lo, H Zhu, X Cao, A Aldrich, F Ali-Osman Cancer research 69 (17), 6790-6798, 2009 | 195 | 2009 |
| IL-6/JAK/STAT3 signaling in breast cancer metastasis: biology and treatment SG Manore, DL Doheny, GL Wong, HW Lo Frontiers in oncology 12, 866014, 2022 | 179 | 2022 |
| EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance HW Lo Current molecular pharmacology 3 (1), 37-52, 2010 | 179 | 2010 |
| Inhibiting TRK proteins in clinical cancer therapy AM Lange, HW Lo Cancers 10 (4), 105, 2018 | 178 | 2018 |
